ライフサイエンスコーパス: Kaposi's sarcoma-associated herpesvirus

1 rcoma (KS) is a multicentric tumor caused by Kaposi's sarcoma-associated herpesvirus.

2 the organization of this protein complex for Kaposi's sarcoma-associated herpesvirus.

3 nfected with either human cytomegalovirus or Kaposi's sarcoma-associated herpesvirus.

4 f the human pathogens Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus.

5 he gammaherpesviruses Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus.

6 ing TRIM43, that control the reactivation of Kaposi's sarcoma-associated herpesvirus.

7 ted with one of oncogenic viruses infection, Kaposi's sarcoma-associated herpesvirus.

8 Similarly, Kaposi's sarcoma-associated herpesvirus also did not sti

9 Unique to gamma-herpesviruses, like Kaposi's sarcoma-associated herpesvirus and Epstein-Barr

10 Kaposi's sarcoma-associated herpesvirus and rhesus macaq

11 ich tumor cells are consistently infected by Kaposi's sarcoma-associated herpesvirus and usually grow

12 d from a newly established and characterized Kaposi's sarcoma-associated herpesvirus- and Epstein-Bar

13 view the evidence for Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus as causal lympho

14 ciated polyomavirus, Epstein-Barr virus, and Kaposi's sarcoma-associated herpesvirus, because GEMs ha

15 Self-assembly of Kaposi's sarcoma-associated herpesvirus capsids occurs w

16 c mechanisms by which Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus cause B-cell lym

17 Kaposi's sarcoma-associated herpesvirus-encoded vFLIP K1

18 Kaposi's sarcoma-associated herpesvirus-encoded viral FL

19 tors (e.g., herpes simplex virus nectin1 and Kaposi's sarcoma-associated herpesvirus EphA2), or assoc

20 ovirus (HCMV), Epstein-Barr virus (EBV), and Kaposi's sarcoma-associated herpesvirus, establish laten

21 IL-4 also reactivated human Kaposi's sarcoma-associated herpesvirus from latency in

22 The Kaposi's sarcoma-associated herpesvirus homologue, ORF61

23 a 50 years ago, only one other virus, namely Kaposi's sarcoma-associated herpesvirus/human herpesviru

24 ed for latent replication and persistence of Kaposi's sarcoma-associated herpesvirus/human herpesviru

25 omolog, the oncogenic human gammaherpesvirus Kaposi's sarcoma-associated herpesvirus/human herpesviru

26 nflammatory activities observed in MCD-like "Kaposi's sarcoma-associated herpesvirus-induced cytokine

27 Microbe, Chang and Ganem (2013) report that Kaposi's sarcoma-associated herpesvirus infection of lym

28 Kaposi's sarcoma-associated herpesvirus is a leading cau

29 coding-polyadenylated nuclear (PAN) RNA from Kaposi's sarcoma-associated herpesvirus is conferred by

30 Kaposi's sarcoma-associated herpesvirus is the causative

31 IFI16 knockdown disrupted the latency of Kaposi's sarcoma associated herpesvirus (KSHV) and induc

32 Kaposi's sarcoma associated herpesvirus (KSHV) establish

33 ing an m(6)A-modified hairpin present in the Kaposi's sarcoma associated herpesvirus (KSHV) ORF50 RNA

34 Human herpes virus 8 (HHV-8), also known as Kaposi's sarcoma associated herpesvirus (KSHV), is an on

35 Kaposi's sarcoma-associated herpesvirus (KSHV [human her

36 r maturation of RRV, the closest relative of Kaposi's sarcoma-associated herpesvirus (KSHV) (a human

37 The Kaposi's sarcoma-associated herpesvirus (KSHV) alkaline

38 ymphomas (PELs) are causally associated with Kaposi's sarcoma-associated herpesvirus (KSHV) and 86% o

39 protein (SCP) of human tumor herpesviruses--Kaposi's sarcoma-associated herpesvirus (KSHV) and Epste

40 Kaposi's sarcoma-associated herpesvirus (KSHV) and Epste

41 Kaposi's sarcoma-associated herpesvirus (KSHV) and Epste

42 ame 50 (ORF50) DNA template in the genome of Kaposi's sarcoma-associated herpesvirus (KSHV) and has b

43 s KSHV-miR-K12-11 and MDV-miR-M4, encoded by Kaposi's sarcoma-associated herpesvirus (KSHV) and Marek

44 Two closely related gammaherpesviruses, Kaposi's sarcoma-associated herpesvirus (KSHV) and rhesu

45 Kaposi's sarcoma-associated herpesvirus (KSHV) and the c

46 Kaposi's sarcoma-associated herpesvirus (KSHV) and the c

47 Both Kaposi's sarcoma-associated herpesvirus (KSHV) and the c

48 ed with the closely related gammaherpesvirus Kaposi's sarcoma-associated herpesvirus (KSHV) and the m

49 Both Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) are human

50 lytic cycles of Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) are induc

51 DNA tumor viruses such as Kaposi's sarcoma-associated herpesvirus (KSHV) are known

52 The vTAs in Kaposi's sarcoma-associated herpesvirus (KSHV) are ORF18

53 al carcinogens, Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) are two o

54 Using the dimeric protease (Pr) from Kaposi's sarcoma-associated herpesvirus (KSHV) as a mode

55 Assembly of Kaposi's sarcoma-associated herpesvirus (KSHV) begins at

56 of arachidonic acid pathways of the host in Kaposi's sarcoma-associated herpesvirus (KSHV) biology h

57 maherpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) cause lif

58 ive stages of the KSHV life cycle.IMPORTANCE Kaposi's sarcoma-associated herpesvirus (KSHV) causes AI

59 Kaposi's sarcoma-associated herpesvirus (KSHV) causes Ka

60 Kaposi's sarcoma-associated herpesvirus (KSHV) causes tw

61 Here, we addressed whether the oncogenic Kaposi's sarcoma-associated herpesvirus (KSHV) deregulat

62 Detectable Kaposi's sarcoma-associated herpesvirus (KSHV) DNA in bl

63 ent SCFAs stimulate lytic gene expression of Kaposi's sarcoma-associated herpesvirus (KSHV) dose depe

64 Human Kaposi's sarcoma-associated herpesvirus (KSHV) effective

65 Kaposi's sarcoma-associated herpesvirus (KSHV) encodes 1

66 Kaposi's sarcoma-associated herpesvirus (KSHV) encodes 1

67 Kaposi's sarcoma-associated herpesvirus (KSHV) encodes 1

68 Kaposi's sarcoma-associated herpesvirus (KSHV) encodes m

69 Kaposi's sarcoma-associated herpesvirus (KSHV) encodes n

70 Kaposi's sarcoma-associated herpesvirus (KSHV) encodes t

71 encoded by open reading frame 36 (ORF36) of Kaposi's sarcoma-associated herpesvirus (KSHV) enhances

72 Kaposi's sarcoma-associated herpesvirus (KSHV) enters hu

73 Latent Kaposi's sarcoma-associated herpesvirus (KSHV) episomes

74 Kaposi's sarcoma-associated herpesvirus (KSHV) establish

75 Kaposi's sarcoma-associated herpesvirus (KSHV) establish

76 Kaposi's sarcoma-associated herpesvirus (KSHV) evades ho

77 We have previously discovered that Kaposi's sarcoma-associated herpesvirus (KSHV) evades th

78 The human oncogenic Kaposi's sarcoma-associated herpesvirus (KSHV) expresses

79 Kaposi's sarcoma-associated herpesvirus (KSHV) expresses

80 Moreover, a recombinant Kaposi's sarcoma-associated herpesvirus (KSHV) expressin

81 inity tagged and purified all 89 proteins of Kaposi's sarcoma-associated herpesvirus (KSHV) from huma

82 Lytic activation of Kaposi's sarcoma-associated herpesvirus (KSHV) from late

83 Reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV) from late

84 ous transcription across the entirety of the Kaposi's sarcoma-associated herpesvirus (KSHV) genome an

85 LANA is essential for tethering the Kaposi's sarcoma-associated herpesvirus (KSHV) genome to

86 e found that most transcripts encoded by the Kaposi's sarcoma-associated herpesvirus (KSHV) genome un

87 Latent Kaposi's sarcoma-associated herpesvirus (KSHV) genomes e

88 The maintenance of latent Kaposi's sarcoma-associated herpesvirus (KSHV) genomes i

89 y focal assembly of RNA polymerase II around Kaposi's sarcoma-associated herpesvirus (KSHV) genomes i

90 ected cells.IMPORTANCE B cells infected with Kaposi's sarcoma-associated herpesvirus (KSHV) harbor mu

91 Kaposi's sarcoma-associated herpesvirus (KSHV) has a cau

92 Kaposi's sarcoma-associated herpesvirus (KSHV) has a sig

93 Kaposi's sarcoma-associated herpesvirus (KSHV) has been

94 Kaposi's sarcoma-associated herpesvirus (KSHV) has been

95 Kaposi's sarcoma-associated herpesvirus (KSHV) has laten

96 Oncogenic Kaposi's sarcoma-associated herpesvirus (KSHV) has laten

97 Kaposi's sarcoma-associated herpesvirus (KSHV) has tropi

98 Here, we report that the Kaposi's sarcoma-associated herpesvirus (KSHV) immediate

99 we present an innovative approach to culture Kaposi's sarcoma-associated herpesvirus (KSHV) infected

100 d levels of viral lytic gene expression when Kaposi's sarcoma-associated herpesvirus (KSHV) infected

101 Kaposi's sarcoma-associated herpesvirus (KSHV) infection

102 Kaposi's sarcoma-associated herpesvirus (KSHV) infection

103 was undertaken to determine whether de novo Kaposi's sarcoma-associated herpesvirus (KSHV) infection

104 an effective small-animal model to study the Kaposi's sarcoma-associated herpesvirus (KSHV) infection

105 Kaposi's sarcoma-associated herpesvirus (KSHV) infection

106 Kaposi's sarcoma-associated herpesvirus (KSHV) infection

107 lar RNA degradation enzyme Xrn1 during lytic Kaposi's sarcoma-associated herpesvirus (KSHV) infection

108 mined the expression of the DDR genes during Kaposi's sarcoma-associated herpesvirus (KSHV) infection

109 The development of a mouse model for Kaposi's sarcoma-associated herpesvirus (KSHV) infection

110 Kaposi's sarcoma-associated herpesvirus (KSHV) infection

111 script C19ORF66 and showed that it restricts Kaposi's sarcoma-associated herpesvirus (KSHV) infection

112 L) is a lymphogenic disorder associated with Kaposi's sarcoma-associated herpesvirus (KSHV) infection

113 Kaposi's sarcoma-associated herpesvirus (KSHV) infects m

114 Latent DNA replication of Kaposi's sarcoma-associated herpesvirus (KSHV) initiates

115 The K15P membrane protein of Kaposi's sarcoma-associated herpesvirus (KSHV) interacts

116 Kaposi's sarcoma-associated herpesvirus (KSHV) interacts

117 The entry of Kaposi's sarcoma-associated herpesvirus (KSHV) into huma

118 Kaposi's sarcoma-associated herpesvirus (KSHV) is a DNA

119 Kaposi's sarcoma-associated herpesvirus (KSHV) is a gamm

120 The ORF45 protein of Kaposi's sarcoma-associated herpesvirus (KSHV) is a gamm

121 Kaposi's sarcoma-associated herpesvirus (KSHV) is a gamm

122 Kaposi's sarcoma (KS) caused by oncogenic Kaposi's sarcoma-associated herpesvirus (KSHV) is a high

123 Kaposi's sarcoma-associated herpesvirus (KSHV) is a huma

124 Kaposi's sarcoma-associated herpesvirus (KSHV) is a huma

125 Kaposi's sarcoma-associated herpesvirus (KSHV) is a huma

126 Kaposi's sarcoma-associated herpesvirus (KSHV) is a huma

127 Kaposi's sarcoma-associated herpesvirus (KSHV) is a huma

128 Kaposi's sarcoma-associated herpesvirus (KSHV) is a huma

129 Kaposi's sarcoma-associated herpesvirus (KSHV) is a huma

130 Kaposi's sarcoma-associated herpesvirus (KSHV) is a huma

131 inhibiting viral gene expression.IMPORTANCE Kaposi's sarcoma-associated herpesvirus (KSHV) is a path

132 Kaposi's sarcoma-associated herpesvirus (KSHV) is a prom

133 ting their premature accumulation.IMPORTANCE Kaposi's sarcoma-associated herpesvirus (KSHV) is an onc

134 Kaposi's sarcoma-associated herpesvirus (KSHV) is an onc

135 predominantly canonical in nature.IMPORTANCE Kaposi's sarcoma-associated herpesvirus (KSHV) is associ

136 Kaposi's sarcoma-associated herpesvirus (KSHV) is associ

137 g the intracellular redox balance.IMPORTANCE Kaposi's sarcoma-associated herpesvirus (KSHV) is associ

138 l that enhance antiviral defenses.IMPORTANCE Kaposi's sarcoma-associated herpesvirus (KSHV) is causal

139 Kaposi's sarcoma-associated herpesvirus (KSHV) is causal

140 Kaposi's sarcoma-associated herpesvirus (KSHV) is causat

141 The K1 gene product of Kaposi's sarcoma-associated herpesvirus (KSHV) is encode

142 Kaposi's sarcoma-associated herpesvirus (KSHV) is etiolo

143 Kaposi's sarcoma-associated herpesvirus (KSHV) is etiolo

144 Kaposi's sarcoma-associated herpesvirus (KSHV) is etiolo

145 Kaposi's sarcoma-associated herpesvirus (KSHV) is etiolo

146 Kaposi's sarcoma-associated herpesvirus (KSHV) is etiolo

147 Kaposi's sarcoma-associated herpesvirus (KSHV) is linked

148 Kaposi's sarcoma-associated herpesvirus (KSHV) is linked

149 Kaposi's sarcoma-associated herpesvirus (KSHV) is linked

150 Kaposi's Sarcoma-associated herpesvirus (KSHV) is mainta

151 Latent infection by Kaposi's sarcoma-associated herpesvirus (KSHV) is requir

152 d transmission in the oral cavity.IMPORTANCE Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

153 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

154 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

155 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

156 Co-infection with HIV-1 and Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

157 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

158 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

159 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

160 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

161 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

162 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

163 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

164 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

165 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

166 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

167 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

168 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

169 Kaposi's sarcoma-associated herpesvirus (KSHV) is the ca

170 Kaposi's sarcoma-associated herpesvirus (KSHV) is the et

171 The DNA virus Kaposi's sarcoma-associated herpesvirus (KSHV) is the et

172 Kaposi's sarcoma-associated herpesvirus (KSHV) is the et

173 Kaposi's sarcoma-associated herpesvirus (KSHV) is the et

174 Kaposi's sarcoma-associated herpesvirus (KSHV) is the et

175 on of the STAT3 signaling pathway.IMPORTANCE Kaposi's sarcoma-associated herpesvirus (KSHV) is the et

176 Kaposi's sarcoma-associated herpesvirus (KSHV) is the et

177 Kaposi's sarcoma-associated herpesvirus (KSHV) is the et

178 Kaposi's sarcoma-associated herpesvirus (KSHV) is the et

179 Kaposi's sarcoma-associated herpesvirus (KSHV) is the et

180 ects in KSHV late gene expression.IMPORTANCE Kaposi's sarcoma-associated herpesvirus (KSHV) is the et

181 Kaposi's sarcoma-associated herpesvirus (KSHV) is the et

182 lytic phases.IMPORTANCE The K15P protein of Kaposi's sarcoma-associated herpesvirus (KSHV) is though

183 Lytic activation of the cancer-causing Kaposi's sarcoma-associated herpesvirus (KSHV) is vital

184 Kaposi's sarcoma-associated herpesvirus (KSHV) K13/vFLIP

185 The Kaposi's sarcoma-associated herpesvirus (KSHV) LANA prot

186 Kaposi's sarcoma-associated herpesvirus (KSHV) latency a

187 We show that the Kaposi's sarcoma-associated herpesvirus (KSHV) latency l

188 Kaposi's sarcoma-associated herpesvirus (KSHV) latency-a

189 HV68) ORF73 (mLANA) has sequence homology to Kaposi's sarcoma-associated herpesvirus (KSHV) latency-a

190 Kaposi's sarcoma-associated herpesvirus (KSHV) latency-a

191 on factors which play important roles in the Kaposi's sarcoma-associated herpesvirus (KSHV) latent an

192 Specific regions of Kaposi's sarcoma-associated herpesvirus (KSHV) latent ep

193 Kaposi's sarcoma-associated herpesvirus (KSHV) latent ge

194 factors (HIFs) play an important role in the Kaposi's sarcoma-associated herpesvirus (KSHV) life cycl

195 e factors (HIFs) play important roles in the Kaposi's sarcoma-associated herpesvirus (KSHV) life cycl

196 r, Ago2 and DCP1A, in PB formation, and that Kaposi's sarcoma-associated herpesvirus (KSHV) lytic inf

197 at the constitutive AMPK activity restricted Kaposi's sarcoma-associated herpesvirus (KSHV) lytic rep

198 veloping germinal center B cells, can induce Kaposi's sarcoma-associated herpesvirus (KSHV) lytic rep

199 Kaposi's sarcoma-associated herpesvirus (KSHV) maintains

200 tic targets to control KS lesions.IMPORTANCE Kaposi's sarcoma-associated herpesvirus (KSHV) manipulat

201 Sequence comparisons to human Kaposi's sarcoma-associated herpesvirus (KSHV) miRNAs re

202 DSBs) in DNA, although detail concerning how Kaposi's sarcoma-associated herpesvirus (KSHV) modulates

203 egy of selectively isolating VLVs by using a Kaposi's sarcoma-associated herpesvirus (KSHV) mutant th

204 Previously, we showed that the Kaposi's sarcoma-associated herpesvirus (KSHV) NEC speci

205 Spontaneous lytic reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV) occurs at

206 The Kaposi's sarcoma-associated herpesvirus (KSHV) open read

207 ere, we identify a viral trimeric complex of Kaposi's sarcoma-associated herpesvirus (KSHV) open read

208 The Kaposi's sarcoma-associated herpesvirus (KSHV) open read

209 The Kaposi's sarcoma-associated herpesvirus (KSHV) ORF36 pro

210 Although Kaposi's sarcoma-associated herpesvirus (KSHV) ORF52 (al

211 We report here that Kaposi's sarcoma-associated herpesvirus (KSHV) ORF52, an

212 The Kaposi's sarcoma-associated herpesvirus (KSHV) ORF57 gen

213 Kaposi's sarcoma-associated herpesvirus (KSHV) ORF57 pla

214 report that PABPC1 forms a complex with the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF57 pro

215 The Kaposi's sarcoma-associated herpesvirus (KSHV) ORF57 pro

216 Kaposi's sarcoma-associated herpesvirus (KSHV) ORF6 is h

217 ncy-associated nuclear antigen (LANA) of the Kaposi's sarcoma-associated herpesvirus (KSHV) performs

218 associated nuclear antigen (LANA) encoded by Kaposi's sarcoma-associated herpesvirus (KSHV) plays a m

219 ORF59 of Kaposi's sarcoma-associated herpesvirus (KSHV) plays an

220 Molecular mechanisms of Kaposi's sarcoma-associated herpesvirus (KSHV) reactivat

221 The lytic replication of Kaposi's sarcoma-associated herpesvirus (KSHV) requires

222 nprecedented mechanism of viral replication: Kaposi's sarcoma-associated herpesvirus (KSHV) stably cl

223 recently showed that the interaction between Kaposi's sarcoma-associated herpesvirus (KSHV) tegument

224 ed to murine gammaherpesvirus 68 (MHV68) and Kaposi's sarcoma-associated herpesvirus (KSHV) that esta

225 e kinase A2 (EphA2) is an entry receptor for Kaposi's sarcoma-associated herpesvirus (KSHV) that is e

226 sociated substrate) as a platform to promote Kaposi's sarcoma-associated herpesvirus (KSHV) trafficki

227 Kaposi's sarcoma-associated herpesvirus (KSHV) transcrib

228 Kaposi's sarcoma-associated herpesvirus (KSHV) transcrip

229 Here we map the 3' UTRs of Kaposi's sarcoma-associated herpesvirus (KSHV) using nex

230 maherpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) utilize c

231 We assessed whether elevated Kaposi's sarcoma-associated herpesvirus (KSHV) viral loa

232 o-electron microscopy (cryo-EM) structure of Kaposi's sarcoma-associated herpesvirus (KSHV) virion, a

233 rophoretic response of B cells infected with Kaposi's sarcoma-associated herpesvirus (KSHV) were inve

234 e expression occurs upon superinfection with Kaposi's sarcoma-associated herpesvirus (KSHV), a common

235 Kaposi's sarcoma-associated herpesvirus (KSHV), a DNA tu

236 We report that ORF10 of Kaposi's sarcoma-associated herpesvirus (KSHV), a nuclea

237 iral FLICE-like inhibitor protein (vFLIP) of Kaposi's sarcoma-associated herpesvirus (KSHV), against

238 Kaposi's sarcoma-associated herpesvirus (KSHV), also kno

239 ncy is an integral part of the life cycle of Kaposi's sarcoma-associated herpesvirus (KSHV), an etiol

240 V1) lineage consists of human herpesvirus 8, Kaposi's sarcoma-associated herpesvirus (KSHV), and clos

241 DNA tumor viruses Epstein-Barr virus (EBV), Kaposi's sarcoma-associated herpesvirus (KSHV), and huma

242 osely related to human herpesvirus 8 (HHV-8)/Kaposi's Sarcoma-associated herpesvirus (KSHV), and it i

243 luding human Epstein-Barr virus (EBV), human Kaposi's sarcoma-associated herpesvirus (KSHV), and muri

244 iruses, including the human gammaherpesvirus Kaposi's sarcoma-associated herpesvirus (KSHV), and the

245 lular reservoir in individuals infected with Kaposi's sarcoma-associated herpesvirus (KSHV), and the

246 the replication of the oncogenic herpesvirus Kaposi's sarcoma-associated herpesvirus (KSHV), by targe

247 aherpesviruses, Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV), can caus

248 , an immediate-early and tegument protein of Kaposi's sarcoma-associated herpesvirus (KSHV), causes s

249 n adaptive immunity, many viruses, including Kaposi's sarcoma-associated herpesvirus (KSHV), have evo

250 othelial cells during de novo infection with Kaposi's sarcoma-associated herpesvirus (KSHV), in cells

251 aherpesviruses, Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV), is assoc

252 (RRV), a close homolog of the human pathogen Kaposi's sarcoma-associated herpesvirus (KSHV), is compr

253 The human gammaherpesvirus, Kaposi's sarcoma-associated herpesvirus (KSHV), is tight

254 by viral endoribonucleases, including SOX in Kaposi's sarcoma-associated herpesvirus (KSHV), muSOX in

255 egument proteins of herpesviruses, including Kaposi's sarcoma-associated herpesvirus (KSHV), play key

256 50 promoters of Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV), respecti

257 Kaposi's sarcoma-associated herpesvirus (KSHV), the caus

258 infection and KS.IMPORTANCE The ability for Kaposi's sarcoma-associated herpesvirus (KSHV), the caus

259 rld primates and are distinct but related to Kaposi's sarcoma-associated herpesvirus (KSHV), the etio

260 Kaposi's sarcoma-associated herpesvirus (KSHV), the etio

261 Kaposi's sarcoma-associated herpesvirus (KSHV), the etio

262 on lymphoma (PEL) cells infected with latent Kaposi's sarcoma-associated herpesvirus (KSHV), the prom

263 In Kaposi's sarcoma-associated herpesvirus (KSHV), these vT

264 (RFHVMn), the pig-tailed macaque homolog of Kaposi's sarcoma-associated herpesvirus (KSHV), was dete

265 viral OX2 (vOX2) immunoregulator encoded by Kaposi's sarcoma-associated herpesvirus (KSHV), we have

266 maherpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV), which ar

267 For oncogenic viruses such as Kaposi's sarcoma-associated herpesvirus (KSHV), which is

268 predominantly infected by the latent form of Kaposi's sarcoma-associated herpesvirus (KSHV), with vir

269 Here, we show that the Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded L

270 The Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded l

271 Kaposi's sarcoma-associated herpesvirus (KSHV)-induced a

272 factor in the development and progression of Kaposi's sarcoma-associated herpesvirus (KSHV)-induced p

273 EBV infection and expressed in many EBV and Kaposi's sarcoma-associated herpesvirus (KSHV)-infected

274 n by HIV-1 promotes the aggressive growth of Kaposi's sarcoma-associated herpesvirus (KSHV)-related m

275 Kaposi's sarcoma-associated herpesvirus (KSHV)-related m

276 shown that, unlike glucose-addicted cancers, Kaposi's sarcoma-associated herpesvirus (KSHV)-transform

277 ies.IMPORTANCE We have previously shown that Kaposi's sarcoma-associated herpesvirus (KSHV)-transform

278 Kaposi's sarcoma-associated herpesvirus (KSHV)-transform

279 nown inflammation related diseases caused by Kaposi's sarcoma-associated herpesvirus (KSHV).

280 for lifelong persistence and pathogenesis of Kaposi's sarcoma-associated herpesvirus (KSHV).

281 erous proliferation of B cells, is caused by Kaposi's sarcoma-associated herpesvirus (KSHV).

282 vo infection of primary endothelial cells by Kaposi's sarcoma-associated herpesvirus (KSHV).

283 hundreds of genes during the reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV).

284 form of aggressive B cell lymphoma caused by Kaposi's sarcoma-associated herpesvirus (KSHV).

285 e switch from latency to the lytic cycle for Kaposi's sarcoma-associated herpesvirus (KSHV).

286 ique subset that is linked to infection with Kaposi's sarcoma-associated herpesvirus (KSHV).

287 EL), which is a viral lymphoma infected with Kaposi's sarcoma-associated herpesvirus (KSHV).

288 Kaposi's sarcoma-associated herpesvirus (KSHV, also call

289 We recently showed that Kaposi's sarcoma-associated herpesvirus (KSHV, or human

290 Kaposi's sarcoma-associated herpesvirus (KSHV; also call

291 The responsible agent, Kaposi's sarcoma-associated herpesvirus (KSHV; HHV8), ex

292 to recognize late gene promoters.IMPORTANCE Kaposi's sarcoma-associated herpesvirus (KSHV; human her

293 16) recognizes nuclear episomal herpesvirus (Kaposi's sarcoma-associated herpesvirus [KSHV], Epstein-

294 ose relative of the human oncogenic pathogen Kaposi's sarcoma-associated herpesvirus, ORF52 is a high

295 EL clinical samples, and three extracavitary Kaposi's sarcoma-associated herpesvirus-positive solid l

296 s, the cofactor activity (CFA), by using the Kaposi's sarcoma-associated herpesvirus RCA homolog Kapo

297 genomes, those of human cytomegalovirus and Kaposi's sarcoma-associated herpesvirus, revealing trans

298 t HIV, together with a transient increase in Kaposi's sarcoma-associated herpesvirus viral load at we

299 73 transcript and the MHV68 ORF63 homolog of Kaposi's sarcoma-associated herpesvirus vNLRP1.

300 be infected with the human pathogens, EBV or Kaposi's sarcoma-associated herpesvirus, we have used a